Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb Study of YM150 in Hip Replacement Surgery
2008-004416-13Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of darexaban in venous thromboembolism (VTE) (5 arms), sponsored by Astellas Pharma. Primary endpoints: Primary composite efficacy endpoint and Safety endpoint. Started Feb 2009; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2008-004416-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004416-13.